DCE-MRI定量参数联合血清VEGF、ProGRP水平检测对肺部良恶性病变的鉴别诊断价值

doi:10.3969/j.issn.1001-8131.2024.02.012

Abstract
Figure/Table
References
Related Citation (7)

Download: PDF (625 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the value of quantitative parameters of dynamic enhanced magnetic resonance imaging（DCE-MRI）combined with serum vascular endothelial growth factor（VEGF）and ProGRP levels in the differential diagnosis of benign and malignant lung lesions. Methods 95 patients with suspected lung cancer were retrospectively selected and divided into benign lesions（46 cases）and malignant lesions（49 cases）according to the biopsy results,and were included in the benign group and malignant group,respectively.The imaging findings of the two groups were compared.Quantitative parameters of DCE-MRI [rate constant（Kep）,volume transfer constant（Ktrans）,extracellular space volume ratio（Ve）] and serum levels of VEGF and ProGRP were compared between the two groups.To analyze the diagnostic value of DCE-MRI quantitative parameters combined with serum VEGF and ProGRP levels in malignant lung lesions. Results The proportion of irregular shape,edge burr sign,uneven internal enhancement and early enhancement rate ≥60% in the malignant group was higher than that in the benign group（P<0.05）.The levels of Kep,Ktrans,Ve and serum VEGF and ProGRP in the malignant group were higher than those in the benign group.The AUC for the combined diagnosis of malignant lung lesions was 0.898,the optimal diagnostic sensitivity was 91.84%,the specificity was 86.96%,and the Yoden index was 0.788. Conclusion Quantitative parameters Kep,Ktrans,Ve and serum VEGF and ProGRP levels of DCE-MRI are closely related to malignant lung lesions.The combined detection has certain diagnostic value,and can be used as an effective method for differentiating benign and malignant lung lesions.

Key words： Dynamic enhanced magnetic resonance imaging Vascular endothelial growth factor Gastrin-releasing peptide precursor Pulmonary disease Differential diagnosis

Received: 25 January 2024

PACS:

R457.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Han Shuliang
	Yang Jie
	Guo Mengke
	Xu Ke

Cite this article:

Han Shuliang,Yang Jie,Guo Mengke, et al. Value of DCE-MRI Quantitative Parameters Combined with Serum VEGF and ProGRP Levels in Differential Diagnosis of Benign and Malignant Lung Lesions[J]. journal1, 2024, 44(2): 37-39.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.02.012 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I2/37

[1] Pei Q,Luo YN,Chen YY,et al.Artificial intelligence in clinical applications for lung cancer:diagnosis,treatment and prognosis[J].Clin Chem Lab Med,2022,60(12):1974-1983.
[2] 张源,赵香田,王明亮,等.基于动态增强MRI影像组学模型鉴别非肝硬化背景下乏脂肪型肝血管平滑肌脂肪瘤和甲胎蛋白阴性肝细胞癌的价值[J].中华医学杂志,2022,102(3):196-200.
[3] 姚宇,刘江波,肖欢.全身骨显像联合血清血管内皮生长因子、糖类抗原153检测对乳腺癌骨转移的诊断价值[J].癌症进展,2023,21(9):1001-1003,1015.
[4] 王欣欣,黄松洁,于洋,等.血清ProGRP、SCCAg及HE4与非小细胞肺癌患者病理特征的关系及其诊断价值分析[J].现代生物医学进展,2020,20(13):2497-2501.
[5] 葛均波,徐永健,王辰.内科学[M].9版.北京:人民卫生出版社,2018:34-35.
[6] Li MY,Liu LZ,Dong M.Progress on pivotal role and application of exosome in lung cancer carcinogenesis,diagnosis,therapy and prognosis[J].Mol Cancer,2021,20(1):22.
[7] 张利安,魏春燕.CT引导下经皮肺穿刺活检对肺癌的诊断价值[J].医学临床研究,2020,37(12):1903-1905.
[8] 姜涵,李自强,付芳芳,等.PET/MRI扩散成像与代谢成像参数在评价肺腺癌Ki-67指数中的价值[J].实用放射学杂志,2023,39(7):1075-1079.
[9] 孟思,周超,李小华,等.肺癌患者DCE-MRI表现特点与其临床病理类型、疾病严重程度的相关性分析[J].哈尔滨医科大学学报,2020,54(02):160-163.
[10] 赵娓娓,宦怡,杨丽,等.DCE-MRI药代动力学参数预估胰腺癌增殖及侵袭转移的可行性初探[J].医学影像学杂志,2021,31(4):620-623.
[11] Zhang BQ,Zhao ZH,Huang YN,et al.Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN,P-Akt and m-TOR in different pathological types of lung cancer[J].BMC Med Imaging,2021,21(1):73.
[12] 魏东,辛运超,刘博,等.pN0期非小细胞肺癌VEGF、Ki-67、p53表达与淋巴结微转移的相关性[J].蚌埠医学院学报,2023,48(5):586-589.
[13] 张涛,张波,张学伟,等.血清CYFRA21-1、CEA、SCC、HE4、ProGRP对肺癌早期诊断及病理类型鉴别的临床价值[J].海南医学,2023,34(9):1281-1285.
[14] 刘文楼,王红梅,秦晓冰,等.血清HE4、VEGF、CYFRA21-1联合检测在非小细胞肺癌诊断中的意义及其与临床病理特征的关系[J].徐州医科大学学报,2020,40(9):625-630.
[15] 秦淑芳,何海妮.ProGRP、SCC-Ag、CYFRA21-1对小细胞肺癌的诊断价值分析[J].实用癌症杂志,2020,35(11):1814-1816.